There is new hope for the prevention and treatment of metabolic diseases
.jpg/:/cr=t:11.54%25,l:11.54%25,w:76.92%25,h:76.92%25/rs=h:500,cg:true,m)
Metabolic Solutions Development Company (MSDC) is a drug discovery and development company investigating new molecular targets and developing novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes.
News to know
Cirius Therapeutics Completes $40 Million Series A Financing to Fund Phase 2b Study of MSDC-0602K in NASH, Adds to Executive Team (Frazier Healthcare Partners and Novo A/S lead new investment)